(Q60197414)

English

Primary Intravitreal Bevacizumab (Avastin) for Diabetic Macular Edema

scientific article published on 01 April 2007

Statements

Primary intravitreal bevacizumab (Avastin) for diabetic macular edema: results from the Pan-American Collaborative Retina Study Group at 6-month follow-up (English)

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit